文献速递炎症性肠病消化道肿瘤与早癌消化内镜

丹麦溃疡性结肠炎50年人群队列:手术、癌症与死亡风险

Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohort.
PubMed 文献 · Aliment Pharmacol Ther · 2021-10-29

该研究纳入1962–1987年丹麦哥本哈根县1161例新发溃疡性结肠炎患者,随访至2017年(中位34年)。诊断后50年结肠切除累积概率为40%(95%CI 36%–44%),小肠癌、结直肠癌、肛管癌及皮肤癌、胰腺癌、甲状腺癌风险高于对照人群,但全因死亡率低于对照人群(校正RR 0.90,95%CI 0.82–0.99)。

要点

  • 诊断后10、20、30、40、50年结肠切除累积概率分别为22%、27%、31%、34%、40%。
  • 小肠癌、结肠癌、直肠癌、肛管癌及皮肤癌、胰腺癌、甲状腺癌风险高于一般人群。
  • 全因死亡率低于对照人群(校正RR 0.90,95%CI 0.82–0.99)。

核心结论

  • 在该1962–1987年诊断的溃疡性结肠炎人群队列中,40%的患者在诊断后50年内接受结肠切除。
  • 溃疡性结肠炎患者肠道及肠外癌症风险升高,但全因死亡率与背景人群相当。

研究设计与样本

  • 基于人群的起始队列研究,纳入1962–1987年丹麦哥本哈根县所有新发溃疡性结肠炎患者1161例。
  • 随访至2017年,中位随访34年(范围0.1–56.0年),诊断时中位年龄33岁(范围2–88岁)。
  • 手术、癌症和死亡信息来自1962–1987年患者档案及1988–2017年丹麦国家患者登记、癌症登记和死因登记。
  • 每例患者与最多50名一般人群个体进行匹配。

主要发现

  • 诊断后10、20、30、40、50年结肠切除累积概率分别为22%(95%CI 20%–25%)、27%(95%CI 25%–30%)、31%(95%CI 28%–34%)、34%(95%CI 31%–37%)、40%(95%CI 36%–44%)。
  • 小肠癌、结肠癌、直肠癌和肛管癌风险高于对照人群。
  • 皮肤癌、胰腺癌和甲状腺癌风险亦高于对照人群。
  • 全因死亡率低于对照人群(校正RR 0.90,95%CI 0.82–0.99)。

临床怎么用

  • 长期随访中应关注溃疡性结肠炎患者的结肠切除风险,诊断后50年累积可达40%。
  • 需警惕溃疡性结肠炎患者肠道及肠外癌症风险升高,包括皮肤癌、胰腺癌和甲状腺癌。
  • 溃疡性结肠炎患者全因死亡率与背景人群相当,但仍有必要进行长期规范化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term data on the natural disease course of unselected patients with ulcerative colitis (UC) are limited. AIMS: To determine the long-term course and prognosis of UC, including patients' risks of surgery, cancer and mortality, in a population-based cohort followed for over 50 years METHODS: All incident patients with UC diagnosed between 1962 and 1987 in Copenhagen County, Denmark were included in a population-based cohort. We extracted information about IBD-related surgeries, cancers and mortality from patient files from 1962 to 1987, and from the Danish National Patient Registry, Cancer Registry, and Register of Causes of Death during 1988-2017. Patients were matched with up to 50 individuals from the general population. RESULTS: We followed 1161 patients for a median of 34 years (range: 0.1-56.0). Median age at diagnosis was 33 years (range: 2-88). The cumulative probability of colectomy 10, 20, 30, 40 and 50 years after diagnosis was 22% (95% CI: 20%-25%), 27% (95% CI: 25%-30%), 31% (95% CI: 28%-34%), 34% (95% CI: 31%-37%), and 40% (95% CI: 36%-44%), respectively. The risk of small intestinal, colon, rectal and anal cancer was higher than among controls, as was cancer of the skin, pancreas and thyroid. All-cause mortality was lower than controls (adjusted RR: 0.90, 95% CI: 0.82-0.99). CONCLUSION: In this population-based cohort of UC patients diagnosed between 1962 and 1987, 40% underwent colectomy within 50 years of diagnosis. Physicians need to be aware that UC patients are at increased risk of intestinal and extra-intestinal cancers. However, UC patients' risk of mortality is comparable to that of the background population.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Burisch J, Lophaven S, Munkholm P, et al. Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohort. Aliment Pharmacol Ther. 2021. PMID: 34713926. doi:10.1111/apt.16677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。